Table 2.

Patients’ operative and clinical data (oropharynx).

Robotic Resection Tool	Patient No.	SRT min	EBL mL	Tumour Subsites	Oral Diet, Days	Time to Tracheostomy Removal, Days	Time to Discharge Days	Complications	Margins	Postoperative Treatment	pTNM	Follow-Up, Months
TY	3	55	10	L, lateral oropharyngeal wall	4	7	7		negative	NO	p T1N0M0	96
TY	4	40	30	R, tongue base	5	7	8	Day 22: bleeding stopped with electrocautery control	negative	NO	p T1N0M0	85
TY	5	50	10	R, tongue base	4	5	7		negative	RT	P T1N1M0	82
TY	6	35	25	L, tongue base	6	11	13		negative	NO	p T1N0M0	78
TY	7	40	30	L, tongue base	6	7	9		negative	NO	p T2N0M0	76
TY	8	50	40	L, tongue base	3	6	7		negative	CH-RT	p T2N1M0	69
CO2	20	40	20	R, tonsil	6	7	8		positive	CH-RT	pT3N1M0	1
EC	9	50	45	R, lateral oropharyngeal wall	8	12	13		close	CH	P T1N0M0	98
EC	10	40	35	L, tonsil	6	7	10		negative	RT-CH	p T1N1M0	95
EC	11	50	25	L, tonsil	5	4	19		positive	RT	p T2N2bM0	52
EC	12	55	35	R, tongue base	9	13	13		close	CH-RT	p T2N2bM0	43
EC	13	40	30	R, tonsil	9	9	11	Intraoperative pharyngotomy Day 12: bleeding stopping with electrocautery control	negative	CH	p T2N1M0	70
EC	14	45	10	R, tonsil	2	9	9	Day 11: bleeding stopped with electrocautery control	positive	RT	pT2N2aM0	57
EC	15	40	45	R, tonsil	5	7	8		negative	RT	p T1N1M0	54
EC	18	45	25	R, tongue base	15	16	20		positive	open surgery	pT1N0MO	18
EC	19	35	35	L, tonsil	9	9	11		negative		pT1N0MO	33

L = left, R = right, SRT = surgical robotic time, EBL = estimated blood loss, RT = radiotherapy, CH = chemotherapy.